product Name:N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
  • SC; N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide; Pilaralisib; XL-147; 3-Fluoro-5-formylbenzonitrile; 3-Cyano-5-fluorobenzaldehyde; N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide; Benzonitrile, 3-fluoro-5-formyl-; XL147; Sar245408; XL 147; N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
  • 956958-53-5;934526-89-3
  • C21H16N6O2S2
  • 448.5207
  • InChI=1/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27)
  • N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide 956958-53-5;934526-89-3
  • 1.538g/cm3
  • 638.9°C at 760 mmHg
  • 1.772
  • 340.2°C
  • 3.22E-16mmHg at 25°C